[1]
Muniz, I.C. da S. et al. 2022. Therapeutic applicability of Zymomonas mobilis on predisposing factors for dyslipidemias and colorectal cancer: A literature review. Infarma - Pharmaceutical Sciences. 34, 3 (Sep. 2022), 222–229. DOI:https://doi.org/10.14450/2318-9312.v34.e3.a2022.pp222-229.